Microfluidic Devices Market (by Device Type, Material, Application, Industry, Geography), Impact of COVID-19, Company Profiles and Recent Developments - Global Forecast to 2028
The global microfluidic devices market is predicted to reach US$ 34.5 Billion by 2028. Microfluidics is the technology that deals with the flow of liquids through microscopic channels such as chips, nozzles, and pumps. Microfluidics is à huge potential area of science which allows high-throughput screening and experimentation that revolve around a series of techniques. The technology is used for processing and manipulating small amounts of liquids using channels that possess micrometer dimensions. With the recent advancements in the biotechnology domain, microfluidic devices promise to be of huge commercial importance. The factors, such as the rising demand for POC testing, high incidence rate of lifestyle diseases, technological advancements, increasing focus on data precision & accuracy, fast returns on investment and faster testing & improved portability through microfluidic chip miniaturization, are driving the market. Moreover, factors such as the growing geriatric population, increasing investments in the healthcare industry, rising demand for advanced technologies and the expansion of private-sector hospitals to rural areas in various countries has boosted the growth of microfluidic devices.
Recent Developments
In April 2022, engineering researchers from Florida Atlantic University’s College of Engineering and Computer Science developed an easy-to-operate and inexpensive microfluidic chip for sperm selection to treat infertility.
uFluidix doubled its manufacturing capacity in 2021 to meet the growing demand for microfluidics.
In May 2021, Nuclera announced the acquisition of E Ink with an aim to expand microfluidic product portfolio by inclusion of E Ink's digital microfluidics unit.
Impact of COVID-19 on Global Microfluidic Devices Market
The COVID–19 outbreak has become a global stress test. As the number of people infected with the virus continues to rise around the world, uncertainties about global economic growth increases. The COVID–19 disease has infected around 553 Million people worldwide. Globally the death toll has reached 6,358,211 according to the latest statistics from the Worldometers (as of July 1, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. COVID-19 has positively impacted the microfluidics market. As countries work to contain the COVID-19 pandemic, the need for effective diagnostic testing has been front and center. Microfluidics has gained a lot of attention with respect to the diagnosis of COVID-19. For instance, US-based researchers from Broad Institute have developed a CRISPR-based molecular diagnostics stage with the help of microfluidics chips to detect viruses in human samples. This single chip has the potential to detect a single virus in more than 1,000 samples at a time. With the outbreak of pandemic COVID-19 every country is increasing expenditure on healthcare, research & development, lab testing devices where the microfluidics also plays a vital role which is likely to boost the growth of the market.
By Device Type – Global Microfluidic Devices Market and Forecast
The chips segment accounted for maximum share of the microfluidic devices market in 2021, followed by the Sensors segment.
Micro needle system plays an important role in pharmaceutical, biotechnology and medical industries.
Globally, the market for microfluidic pumps is gaining significant importance due to growing R&D investment in life sciences, pharmaceuticals, and increasing point of care testing demand.
By Material – Global Microfluidic Devices Market and Forecast
Silicon and glass were the original materials first used for microfluidic applications. Silicon was first selected due to its resistance to organic solvents, ease in metal depositing, high thermo-conductivity, and stable electroosmotic mobility
The polymers segment accounts for highest share of the global microfluidic devices market, as polymers are cheaper material and allow for quick fabrication processes in comparison to silicon and glass.
By Application – Global Microfluidic Devices Market and Forecast
Pharmaceutical and life sciences research commands the largest share of the microfluidic devices market, followed by the Clinical and veterinary diagnostics segment.
Point-of-care diagnostic devices founded in microfluidic technologies will lead the change to personalized medicine, thereby, having a great effect in the diagnosis and treatment of diseases.
Drug delivery and analytical devices application segments are competing very closely with each other to grab maximum share of the pie.
By Industry – Global Microfluidic Devices Market and Forecast
In-vitro diagnostics remained the largest segment type by industry, accounting for around 50% share of the microfluidic devices market in 2021.
Microfluidic technologies are emerging as powerful tools for the drug discovery and development processes.
The technological advancements in medical devices such as miniaturization, automation and enhanced functionality with help of complex electrical control, mechanical properties are major factors driving the global microfluidics medical devices market.
By Geography - Microfluidic Devices Market and Forecast
North America accounted for largest share of the microfluidic devices market, followed by Europe.
In Europe microfluidic devices market, Germany accounted for the largest market share in 2021.
The United Kingdom has observed the fastest growth in the Europe microfluidics market in the past few years.
Asia Pacific is the fastest growing market for microfluidic devices.
It is predicted that the Middle East and Africa will account for 4% share of the microfluidic devices market by 2028.
iGATE RESEARCH report titled “Microfluidic Devices Market (by Device Type, Material, Application, Industry, Geography), Impact of COVID-19, Company Profiles and Recent Developments - Global Forecast to 2028” provides a comprehensive assessment of the fast-evolving, high-growth Global Microfluidic Devices Market.
This 172 Page report with 84 Figures and 10 Tables has been analyzed from 10 viewpoints:
1. Global Microfluidic Devices Market and Forecast (2015 – 2028)
2. Impact of COVID-19 on Global Microfluidic Devices Market
3. By Device Type – Global Microfluidic Devices Market and Forecast (2015 – 2028)
4. By Material – Global Microfluidic Devices Market and Forecast (2015 – 2028)
5. By Application – Global Microfluidic Devices Market and Forecast (2015 – 2028)
6. By Industry – Global Microfluidic Devices Market and Forecast (2015 – 2028)
7. By Geography - Microfluidic Devices Market and Forecast (2015 – 2028)
8. Global Microfluidic Devices Market – Recent Developments
9. Global Microfluidic Devices Market – Company Profiles
10. Global Microfluidic Devices Market - Driving Factors & Challenges
By Device Type – Global Microfluidic Devices Market and Forecast
1. Chips
2. Micro Pumps
3. Sensors
4. Micro Needles
5. Others
By Material – Global Microfluidic Devices Market and Forecast
1. Silicon
2. Glass
3. Polymers
4. Others
By Application – Global Microfluidic Devices Market and Forecast
Pharmaceuticals and Life Sciences Research
Clinical and Veterinary Diagnostics
Point of Care Diagnostics
Analytical Devices
Drug Delivery
Environmental and Industrial
Others
By Industry – Global Microfluidic Devices Market and Forecast
1. In- Vitro Diagnostics
2. Pharmaceuticals
3. Medical Devices
4. Others
By Geography - Microfluidic Devices Market and Forecast
1. North America
United States
Canada
Rest of North America
2. Europe
Germany
France
Italy
Spain
United Kingdom
Netherlands
Switzerland
Belgium
Rest of Europe
3. Asia Pacific
Japan
China
India
Rest of Asia Pacific
4. Latin America
5. Middle East & Africa
Global Microfluidic Devices Market – Company Profiles
1. uFluidix
2. PerkinElmer Inc.
3. Standard BioTools (Previously Fluidigm)
4. Blacktrace Holdings Ltd. (Dolomite Microfluidic)
5. Micronit
6. BioFluidix Gmbh
7. Fluigent
8. ALine Inc.
9. Philips
10. Danaher Corporation
11. Thermo Fisher Scientific
12. Agilent Technologies
13. Becton, Dickinson and Company
14. Illumina, Inc.
15. Abbott Laboratories
16. Quidel Corporation
17. Abaxis, Inc.
18. Nanōmix, Inc. (Formerly known as Covalent Materials, Inc.)
19. Biosurfit SA
20. Micropoint Bioscience, Inc.
21. Siloam Biosciences, Inc.
22. NanoEnTek Inc.
23. OPKO Health, Inc.
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook